LEUKOTAC ® (inolimomab) is available again in France, following the granting of cohort ATU for the treatment of graft-versus-host disease, corticosteroid-resistant or corticosteroid-dependent, with grade II-IV
January 09, 2020 07:00 ET
|
Elsalys Biotech
LEUKOTAC ® (inolimomab) is available again in France, following the granting of cohort ATU for the treatment of graft-versus-host disease, corticosteroid-resistant or corticosteroid-dependent, with...
Hematopoietic Stem Cell Transplantation - Global Clinical Trials Review, H2, 2015: ResearchMoz
March 23, 2016 09:00 ET
|
Researchmoz Global Pvt Ltd
Albany, NY, March 23, 2016 (GLOBE NEWSWIRE) -- The report aims to help readers make effective business strategies by understanding the prevalent hematopoietic stem cell transplantation market...